Another anti-IL-13 mAb (Dectrekumab or QAX576) has demonstrated improvement in the esophageal eosinophil count and in the EoE-related transcription profile expression in a small placebo-controlled RCT on 17 EoE patients [99]. The gene discussed is IL13; the disease is eosinophilic esophagitis.